18-month data of IOL-mounted drug delivery platform shows impressive results in IOP, visual acuity

Published on May 1, 2025
Results from the first-in-human study of SpyGlass Pharma's bimatoprost-eluting IOL showed significant reduction in IOP and improved best-corrected distance visual acuity.
Continue reading on website
Other news

UPTE-CWA 9119, AFSCME unions cite UC's "unfair labor practices" in May 1 strikes

May 1, 2025
The strikes follow the University of Californi’s hiring freeze implemented on March 19.

Hoya Reports Revenue Growth in 2024 Fourth Quarter and Full-Year, Cautions of Possible Impact From Tariffs

May 2, 2025
TOKYO—Hoya Corporation (7741:Tokyo) has announced consolidated revenue of 216.8 billion yen for the fourth quarter ending March 31, 2025, up 10.1 percent from the same period in 2024, and up 11 percent on a constant currency basis. Operating profit increased due to continued efficient operations around production in the IT business and improved profitability in the Life Care business, according to